Core Biogenesis
PrivateLast Round
Series A
Jul 28, 2022
Total Funding Raised
$14.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Core Biogenesis is a biotechnology company that develops a plant-based bioproduction platform to manufacture recombinant proteins for the cell therapy, cellular agriculture, and skincare industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Core Biogenesis Comparables
Compare Core Biogenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ORF Genetics | 85% | |
| Bright Biotech | 83% | |
| BioBetter | 83% |
Core Biogenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2022 | ||||
| Grant | Jun 10, 2022 | ||||
| Seed | Dec 14, 2020 |
Key People
Founding team and executive leadership
Core Biogenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Seed |
| European Innovation Council | Grant |
| Blue Horizon | Series A |
| Thia Ventures | Series A |
| XAnge | Seed, Series A |
| Entrepreneurs First | Seed, Series A |
| Blue Horizon Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 896% MoM.
- Jul 20, 2026
Open roles increased from 0 to 9, representing 29% of headcount.
Recent news
Latest coverage and updates
- attends_eventOct 24, 2026
Core Biogenesis receives Best Paper in the Personal Care category at the 2026 SOFW Awards in France on Oct 22nd '26 for its article on Oleosome-FGF-2 and hair density.
- receives_awardOct 24, 2026
Core Biogenesis receives the SOFW Award after its paper on oleosome FGF-2 improving hair density in 28 days is selected as Best Paper in Personal Care.
- receives_awardOct 24, 2026
At the 2026 SOFW Awards in France on Oct 22nd '26, Core Biogenesis receives Best Paper in the Personal Care category from the SOFW Award jury for its scientific article on Oleosome-FGF-2 and hair density.
- attends_eventOct 24, 2026
Core Biogenesis wins Best Paper in Personal Care at the 2026 SOFW Awards for Clinical Research on Hair Density on Oct 22nd '26 for its paper on oleosome-FGF-2 technology and hair density.
- recognized_asOct 24, 2026
The SOFW Awards recognize Core Biogenesis's research as Best Paper in Personal Care, acknowledging its scientific contribution and the potential relevance of its oleosome-based biomimetic growth factor technology to future hair and scalp care formulations.
Core Biogenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Core Biogenesis's valuation, stock price, and market status.
Is Core Biogenesis a public or private company?
Core Biogenesis is a private company.
What is the current stock price of Core Biogenesis?
Core Biogenesis is a private company, so its shares have no public market price. Caplight tracks Core Biogenesis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Core Biogenesis worth (valuation)?
Valuation information for Core Biogenesis is not publicly available.
Can I buy Core Biogenesis stock?
Core Biogenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Core Biogenesis's last funding round?
Core Biogenesis's most recent funding round was Series A on July 28, 2022.
Who are the main investors in Core Biogenesis?
Key investors in Core Biogenesis include XAnge.
Will Core Biogenesis IPO soon?
No public IPO plans have been announced for Core Biogenesis.
How can I track Core Biogenesis secondary market activity?
Caplight tracks bids, offers, and trades in Core Biogenesis's shares on secondary markets.